Difficulty: Medium
Average Score: 95%
Practice
Tick the drug, inhibiting viral proteases:
Correct answer
C
Rationale
The correct answer is C) Saquinavir, which inhibits viral proteases. Proteases are enzymes that viruses use to replicate within host cells. By inhibiting these proteases, the virus's ability to replicate and spread is disrupted, thereby helping to control the viral infection.
Option A) Rimantadine is an antiviral medication used to treat and prevent influenza A virus infections by inhibiting viral replication, but it does not target viral proteases.
Option B) Acyclovir is an antiviral medication used to treat herpes simplex virus and varicella-zoster virus infections by interfering with viral DNA synthesis, not viral proteases.
Option D) Zalcitabine is an antiretroviral medication used to treat HIV infections by inhibiting reverse transcriptase, an enzyme that HIV uses to replicate its genetic material, not viral proteases.
In an educational context, understanding the mechanisms of action of different pharmacological treatments is crucial for providing effective care to clients across the lifespan. Knowledge of how specific drugs target different stages of viral replication can help healthcare professionals make informed decisions when selecting treatments for their patients.
Option A) Rimantadine is an antiviral medication used to treat and prevent influenza A virus infections by inhibiting viral replication, but it does not target viral proteases.
Option B) Acyclovir is an antiviral medication used to treat herpes simplex virus and varicella-zoster virus infections by interfering with viral DNA synthesis, not viral proteases.
Option D) Zalcitabine is an antiretroviral medication used to treat HIV infections by inhibiting reverse transcriptase, an enzyme that HIV uses to replicate its genetic material, not viral proteases.
In an educational context, understanding the mechanisms of action of different pharmacological treatments is crucial for providing effective care to clients across the lifespan. Knowledge of how specific drugs target different stages of viral replication can help healthcare professionals make informed decisions when selecting treatments for their patients.